Загрузка...
ALS blood expression profiling identifies new biomarkers, patient subgroups, and evidence for neutrophilia and hypoxia
BACKGROUND: Amyotrophic lateral sclerosis (ALS) is a debilitating disease with few treatment options. Progress towards new therapies requires validated disease biomarkers, but there is no consensus on which fluid-based measures are most informative. METHODS: This study analyzed microarray data deriv...
Сохранить в:
| Опубликовано в: : | J Transl Med |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6530130/ https://ncbi.nlm.nih.gov/pubmed/31118040 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-019-1909-0 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|